Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

In this article, you’ll find some of the top content that was published on LCGC this week, including details on the recent merger between Waters Corporation and BD Biosciences.

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...

Shares of West Pharmaceutical Services Inc. slipped 4.83% to $210.89 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.01% to ...

Naturally, dividend stocks, especially high-yielding ones, are alluring. That said, nothing in life is guaranteed, and ...

Explore the insights of the Biopsy Devices Companies Quadrant—a comprehensive analysis of the global biopsy device market. This report evaluates over 140 companies, highlighting the top 15 leaders ...

Insider buying fuels Davenport’s contrarian bets in semis, housing, and LNG. See what signals fund managers trust when ...

Overview of Sepsis Diagnostics MarketThe Global Sepsis Diagnostics Market is valued at USD 1.15 Billion in 2024 and is ...

The medtech industry holds a great deal of potential, spurred on by innovative tech. But, there are also significant ...